The long-term objective of this five-year plan is to elucidate the etiology and pathogenesis of insulin-dependent diabetes mellitus (IDDM). The proposed investigations are a logical extension of a nationwide Swedish Registry, established in 1983 for incident cases of IDDM patients developing diabetes at 15-34 years of age. The unique resources of the Swedish Registry will be utilized in a case-control study to define genetic, autoimmune and viral antibody markers for the development of IDDM. The controls will be selected based on the Swedish civic registration numbers to identify individuals who are matched for age and sex. Comparisons will be made to a case-control study of 0-14 year old individuals analyzed with the same methods. The primary goal is to determine whether the same genetic and environmental markers known to be associated with IDDM in the 0-14 year age group are also operative in the 15-34 year group. The reasons to further study the 15-34 year olds are two-fold. First, this is an age group where both IDDM and NIDDM is present. It therefore offers an opportunity to study conversion rates from NIDDM to IDDM and the factors that influence these. Second, this age group is particularly suited to test the hypothesis that genetic and antibody markers alone or in combination permit a differential diagnosis of diabetes mellitus at the time of clinical onset. Specifically, we will: 1) investigate the association between IDDM and markers at the HLA-DQ locus and estimate how age and sex modify the relative risks associated with each of these markers; 2) identify a nucleotide sequence that is present in all of the IDDM patients in 4-kb and 12-kb HLA-DQ associated BamH1 fragments cloned from a patient with IDDM; 3) determine if certain levels or combinations of islet cell and other organ-specific autoantibodies alone or in combination with the HLA gene(s) are markers for IDDM and determine the rate of conversion from NIDDM to IDDM, and (4) estimate the strength of association between IDDM and viral antibody titers and determine by means of multiple logistic regression analysis the joint association of viral antibody, autoantibodies, and HLA specificities with IDDM. It will be determined whether a specific virus plays a role of an independent cofactor or whether the HLA specificities mediate a risk of viral infection. These studies will help to define the mechanisms which result in IDDM and to produce insights leading to the possibility of prevention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042654-04
Application #
2142445
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1991-09-01
Project End
1996-04-30
Budget Start
1994-09-15
Budget End
1996-04-30
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Ingemansson, Sofie; Vaziri-Sani, Fariba; Lindblad, Ulf et al. (2013) Long-term sustained autoimmune response to beta cell specific zinc transporter (ZnT8, W, R, Q) in young adult patients with preserved beta cell function at diagnosis of diabetes. Autoimmunity 46:50-61
Törn, Carina; Ingemansson, Sofie; Lindblad, Ulf et al. (2011) Excess mortality in middle-aged men with diabetes aged 15-34 years at diagnosis. Acta Diabetol 48:197-202
Jensen, Richard A; Agardh, Elisabet; Lernmark, Ake et al. (2011) HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later. PLoS One 6:e17569
Ramagopalan, S V; Link, J; Byrnes, J K et al. (2009) HLA-DRB1 and month of birth in multiple sclerosis. Neurology 73:2107-11
Jensen, R; Gilliam, L; Torn, C et al. (2007) Islet cell autoantibody levels after the diagnosis of young adult diabetic patients. Diabet Med 24:1221-8
Jensen, Richard A; Gilliam, Lisa K; Torn, Carina et al. (2007) Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects. J Diabetes Complications 21:205-13
Padoa, C J; Crowther, N J; Thomas, J W et al. (2005) Epitope analysis of insulin autoantibodies using recombinant Fab. Clin Exp Immunol 140:564-71
Luo, D; Gilliam, L K; Greenbaum, C et al. (2004) Conformation-dependent GAD65 autoantibodies in diabetes. Diabetologia 47:1581-91
Torn, Carina (2003) C-peptide and autoimmune markers in diabetes. Clin Lab 49:1-10
Littorin, B; Nystrom, L; Gullberg, B et al. (2003) Increasing body mass index at diagnosis of diabetes in young adult people during 1983-1999 in the Diabetes Incidence Study in Sweden (DISS). J Intern Med 254:251-6

Showing the most recent 10 out of 70 publications